iFabrick (IFA) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Q2 revenues reached $9.6M, up 65% year-over-year, with six-month revenues at a record $37.1M, up 188% year-over-year, marking the strongest six-month period in company history.
Both Intelligent Fabrics and Coconut Grove divisions achieved all-time high revenues, driven by new product launches, expanded programs, and replenishment initiatives.
EBITDA for Q2 was $715K, a $1M turnaround from the prior year; six-month EBITDA hit a record $5.8M.
Balance sheet strengthened by a $21M capital raise, ending Q2 with $25M in cash and $45.1M working capital.
Significant momentum entering the second half of 2026, supported by strong execution and successful capital raise.
Financial highlights
H1 2026 revenue rose 188% year-over-year to $37.1M; Q2 2026 revenue up 65% to $9.6M.
Q2 revenues: $9.6M (reported), $10.3M invoiced before $650K advertising deduction per IFRS.
Gross margin declined to 30% in Q2 2026 (from 37% in Q2 2025) and to 32% in H1 2026 (from 38% in H1 2025), mainly due to product mix and marketing support deductions.
H1 2026 EBITDA was $5.78M, compared to negative $0.10M in H1 2025; Q2 2026 EBITDA was $0.71M, up from negative $0.29M.
Net earnings for Q2 2026 were $238,597 ($0.007/share), compared to a net loss of $190,103 in Q2 2025.
Outlook and guidance
Q3 expected to be replenishment-focused, with potential for one set program; Q1 and Q4 remain largest quarters due to seasonality.
Management expects continued momentum in the second half of 2026, with strong demand for new programs and expanded product offerings.
Long-term EBITDA margin target of 15-20% could be achieved as early as this year.
Dividend initiation possible within two years, contingent on maintaining strong cash position.
Latest events from iFabrick
- Clinically validated textile tech, rapid growth, and major retail traction drive strong outlook.IFA
Corporate presentation - Record Q1 revenue of $27.5M, up 288%, driven by new products and retail expansion.IFA
Q1 2026 - Clinically validated textile platform achieves record growth and expands into new markets.IFA
Investor presentation - Record revenue and strong Q1 2026 outlook, with margin recovery expected as tariffs ease.IFA
Q4 2025 - Q3 2025 revenue jumped 111% year-over-year, with margin pressure expected to ease ahead.IFA
Q3 2025 - Record deposits and new market entry drive strong future growth despite margin pressure.IFA
Q2 2025 - Proprietary textile technologies and medical focus drive strong growth and global expansion.IFA
Planet MicroCap Showcase: VEGAS 2025 - Record Q1 revenue achieved, but margin pressure and higher costs reduced earnings.IFA
Q1 2025 - Record revenue and profitability in 2024, with double-digit growth expected in 2025.IFA
Q4 2024